Mohr Davidow Ventures, a Menlo Park, Calif. firm, has hired two biotech experts to help it make prudent investments in personalized healthcare companies. Essentially, they will look for startups that apply technology to give patients more control over their medical experiences, and to cut costs for care providers and drug developers.
Interventional Dynamics, a medical tech research company. Whiteley, now executive in residence at MDV, cofounded therapeutics provider Anaphore, and has since worked pharmaceutical companies Perlegen Sciences and F. Hoffman-La Roche.
While Riskin will be primarily responsible for selecting promising startups and products, Whiteley will work with existing portfolio companies to advance their business models.
